American Well Corporation

American Well Corporation(AMWL)股票分析

$12.350

-0.378 (-3.06%)收盤時

Loading chart…
最高
13.810
開盤
12.590
成交量加權均價
12.65
成交量
181.78K
市值
111.26M
最低
11.800
成交金額
2.30M
企業價值/稅息折舊攤銷前利潤(TTM)
-2.67

American Well Corporation operates a hybrid care, delivery enablement platform in the United States and globally, connecting and enabling providers, payers, patients, and innovators to deliver access to more affordable quality care. It offers a single, comprehensive platform to support all digital health needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. The Amwell Converge platform offers data architecture and video capabilities, flexibility and scalability, as well as a user experience focused on the needs of patients, members and providers. For health systems, its enterprise platform enables provider-to-provider virtual care for use cases ranging from stroke to virtual nursing and e-sitting. Its Amwell Carepoint devices enable healthcare providers to leverage proprietary carts and transform existing tablets and TVs into digital access points in clinical settings, helping to address personnel shortages and access limitations.

AI 分析 of American Well Corporation (AMWL)

持有

American Well Corp is currently a hold. The stock is priced at $12.52, which is below the average analyst price target of $12, indicating limited upside potential in the near term. The RSI is at 37.8, suggesting the stock is nearing oversold territory, but the recent 5-day change of -7.53% indicates downward momentum. The company has shown improvement with a narrowed net loss of $9.6 million in Q2 2026, but risks remain due to ongoing losses and competitive pressures in the telehealth market.

估值指標

American Well Corporation(AMWL)目前預期本益比為 0.00,5 年平均預期本益比為 -9.48。

預期本益比

合理
5 年均值 P/E
-9.48
目前P/E
0.00
高估
16.43
低估
-35.40

預期 EV/EBITDA

低估
5 年均值 EV/EBITDA
-0.18
目前EV/EBITDA
-2.67
高估
2.24
低估
-2.60

預期股價營收比

合理
5 年均值 P/S
1.69
目前P/S
1.02
高估
3.23
低估
0.15

Alphio AI 對 AMWL 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%AMWL

$8.60

情境價格

基

基準

基準 · 50%AMWL

$7.73

情境價格

悲

悲觀

悲觀 · 25%AMWL

$7.23

情境價格

持有 AMWL 的大戶

C

Cable Car Capital LLC

+ 持有AMWL

-4.58%

3個月報酬率

S

Senvest Management, LLC

+ 持有AMWL

-5.89%

3個月報酬率

事件時間軸

2026-11-03 (ET)

17:00:00

Company Sees Q4 Adjusted EBITDA of $0M-$1M

17:00:00

Amwell Reports Q3 Revenue of $48.99M, Beating Expectations

17:00:00

Company Raises 2026 Revenue Outlook to $203.15M

2026-09-08 (ET)

08:30:00

Amwell to Deploy Virtual Health Platform for VA

2026-08-04 (ET)

17:00:00

Adjusts FY26 EBITDA Loss Outlook to $7M-$9M

資訊

AMWL 常見問題 —— 由 Alphio AI 解答

American Well Corporation operates a hybrid care, delivery enablement platform in the United States and globally, connecting and enabling providers, payers, patients, and innovators to deliver access to more affordable quality care. It offers a single, comprehensive platform to support all digital health needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. The Amwell Converge platform offers data architecture and video capabilities, flexibility and scalability, as well as a user experience focused on the needs of patients, members and providers. For health systems, its enterprise platform enables provider-to-provider virtual care for use cases ranging from stroke to virtual nursing and e-sitting. Its Amwell Carepoint devices enable healthcare providers to leverage proprietary carts and transform existing tablets and TVs into digital access points in clinical settings, helping to address personnel shortages and access limitations. It operates in the Healthcare sector (SERVICES-BUSINESS SERVICES, NEC industry).

American Well Corp is currently a hold. The stock is priced at $12.52, which is below the average analyst price target of $12, indicating limited upside potential in the near term. The RSI is at 37.8, suggesting the stock is nearing oversold territory, but the recent 5-day change of -7.53% indicates downward momentum. The company has shown improvement with a narrowed net loss of $9.6 million in Q2 2026, but risks remain due to ongoing losses and competitive pressures in the telehealth market.

暫無貼文

註冊或登入後參與討論

相關文章

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易